Development and Validation of an Individualized Immune Prognostic Signature in Early-Stage Nonsquamous Non–Small Cell Lung Cancer

Title
Development and Validation of an Individualized Immune Prognostic Signature in Early-Stage Nonsquamous Non–Small Cell Lung Cancer
Authors
Keywords
-
Journal
JAMA Oncology
Volume 3, Issue 11, Pages 1529
Publisher
American Medical Association (AMA)
Online
2017-07-07
DOI
10.1001/jamaoncol.2017.1609

Ask authors/readers for more resources

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation